Stockreport

OverT Bio Announces the Formation of the Clinical Advisory Board to Support the Clinical Development of OVT-101 in Ovarian Cancer and Other Solid Tumors [Yahoo! Finance]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF NEW YORK, March 23, 2026 BUSINESS WIRE OverT Bio , a biotechnology company developing next-generation therapies for solid tumors, today announced the formation of its C [Read more]